#NovoNordisk #DiabetesCare #WeeklyInsulin #Awiqli #HealthcareNews Neetu Chandra Sharma | Vikrant Shrotriya | Novo Nordisk To view or add a comment, sign in Novo Nordisk Launches Awiqli, Worlds First Weekly Basal Insulin In India Novo Nordisk has launched Awiqli (insulin icodec), the worlds first once-weekly basal insulin, in India
Your dose is then increased every four weeks (0.5 mg, 1.0 mg, 1.7 mg) until you reach the full maintenance dose of 2.4 mg
2015;doi:10.1056/NEJMoa1411892
Jump to: Understanding both medications | How these medications work together | Safety considerations | When to contact your doctor | Practical advice | Frequently asked questions | Take home message You can take Mounjaro (tirzepatide) alongside spironolactone or other mineralocorticoid receptor antagonists (MRAs), but regular monitoring is essential
ANCOVA comparing mean GIDYQ scores between diagnostic groups Results showed that sex assigned at birth was not significantly related to mean GIDYQ scores, F (1,226) = .024, p = .877, partial 2 = .000
The 2.5mg starting dose needs just 25 units